WASHINGTON: The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in Alzheimer’s patients.The FDA approval of the drug, Leqembi, also known as lecanemab, came just days after the agency was harshly criticized in a congressional report for its green-lighting of another Alzheimer’s drug, Aduhelm.Preliminary data from a trial of Leqembi was released in September and found it slowed cognitive decline in Alzheimer’s patients by 27 percent across an 18-month period.Leqembi and Aduhelm “represent an important advancement in the ongoing fight to effectively treat Alzheimer’s disease,“ the FDA said in a statement.Both drugs were approv
Hence then, the article about us approves new drug to treat alzheimer s was published today ( ) and is available onDaily Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( US approves new drug to treat Alzheimer’s )